📌 LADA (Latent Autoimmune Diabetes in Adults) is a slowly progressing form of autoimmune diabetes that occurs in adulthood. Often referred to as "Type 1.5 diabetes," it shares characteristics of both Type 1 (autoimmune origin) and Type 2 (adult onset). The condition arises when the immune system mistakenly attacks the insulin-producing beta cells of the pancreas. It is most often diagnosed between the ages of 30 and 50 and is frequently misdiagnosed as Type 2 diabetes initially due to its slower progression compared to classic juvenile onset.☝️Main Symptoms: Symptoms develop more gradually than in Type 1 diabetes but typically include:🔹Persistent thirst (polydipsia) and dry mouth.🔹Frequent urination (polyuria), especially at night.🔹Unexplained weight loss despite normal appetite (unlike the weight gain often seen in Type 2).🔹Chronic fatigue and weakness, particularly after meals.🔹Blurred vision or difficulty focusing.🔹Slow wound healing and susceptibility to infections.🔹Tingling or numbness in the hands or feet (neuropathy).🔹Lack of significant obesity (patients often have a healthy BMI or are only slightly overweight). 🩸Diagnosis: Accurate diagnosis requires distinguishing LADA from Type 2 diabetes, as clinical presentation can be similar. Key investigations include:🔹Antibody Screening.🔹C-peptide Test.🔹HbA1c.🔹Absence of severe insulin resistance typically associated with metabolic syndrome.💊Treatment: The primary goal is to preserve residual beta-cell function and strictly control glucose levels. Treatment strategies differ from standard Type 2 care:🔹Insulin Therapy.🔹Diet and Lifestyle.🔹Medication Adjustments: While metformin may be used initially, drugs like sulfonylureas (which stimulate the pancreas) are generally contraindicated as they accelerate beta-cell burnout.🔹Continuous Glucose Monitoring (CGM) to track real-time blood sugar trends.‼️Important: LADA is particularly dangerous due to the high risk of misdiagnosis. Treating it as Type 2 diabetes with medications that overstimulate the pancreas can lead to a rapid depletion of the body's own insulin and the early onset of complications (such as kidney disease, vision loss, or nerve damage). Early identification of autoimmune markers and timely transition to appropriate therapy are crucial for improving prognosis and maintaining quality of life.